Jennison Associates
SOPH icon

Jennison Associates’s SOPHiA GENETICS SOPH Stock Holding History

Jennison Associates’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,209,055
Closed -$2.49M – 624
2022
Q4 		$2.49M Sell
1,209,055
-34,193
-3% -$76.8K ﹤0.01% 443
2022
Q3 		$3.27M Buy
1,243,248
+3,834
+0.3% +$13.4K ﹤0.01% 445
2022
Q2 		$4.49M Sell
1,239,414
-259,626
-17% -$1.32M ﹤0.01% 435
2022
Q1 		$11.6M Buy
1,499,040
+57,450
+4% +$645K 0.01% 406
2021
Q4 		$20.3M Buy
1,441,590
+796,173
+123% +$11.7M 0.01% 364
2021
Q3 		$11.3M Buy
+645,417
New +$11.4M 0.01% 436

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Jennison Associates's SOPH Position: Q1 2023 in Review

Jennison Associates sold out of SOPHiA GENETICS (SOPH) in Q1 2023, closing a stake of 1,209,055 shares — an estimated $2.49M sold.

Jennison Associates first reported a position in SOPH in Q3 2021 and held it in 6 quarters. The position peaked at $20.3M in Q4 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q1 2023.

  • Jennison Associates reported no remaining SOPHiA GENETICS position as of Q1 2023 after selling out during the quarter.
  • Jennison Associates sold 1,209,055 SOPHiA GENETICS shares in Q1 2023, an estimated $2.49M.
  • Jennison Associates first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 6 quarters.
  • Jennison Associates's SOPHiA GENETICS position peaked at $20.3M in Q4 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2023.

Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.